Campbell, Michael J <br/><br/>
Vandetanib and the management of advanced medullary thyroid cancer.  [electronic resource] 

 -  Current opinion in oncology  Jan 2013 
 - 39-43 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1531-703X 
<br/><br/><label>Standard No.: </label>10.1097/CCO.0b013e32835a42b9  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--adverse effects<br/>Carcinoma, Medullary--drug therapy<br/>Clinical Trials as Topic<br/>Humans<br/>Piperidines--adverse effects<br/>Protein Kinase Inhibitors--adverse effects<br/>Proto-Oncogene Mas<br/>Quinazolines--adverse effects<br/>Thyroid Neoplasms--drug therapy